Netherlands· NL-85eac31770ea
Hylan 0,15/0,15 mg/ml, oogdruppels, oplossing in verpakking voor eenmalig gebruik
A künstliche tränenflüssigkeit und sonstige indifferente präparate product containing carbomeer 981 + natriumhyaluronaat, registered in Netherlands by Pharma Stulln GmbH. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Künstliche tränenflüssigkeit und sonstige indifferente präparate is registered in 11 of 19 countries.
Countries holding a registration under ATC S01XA20 (künstliche tränenflüssigkeit und sonstige indifferente präparate), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Künstliche tränenflüssigkeit und sonstige indifferente präparate · ATC S01XA20
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- CARBOMEER 981 + NATRIUMHYALURONAAT
- Manufacturer
- Pharma Stulln GmbH
- Country
- Netherlands (NL)
- ATC code
- S01XA20
- ATC class
- Künstliche Tränenflüssigkeit und sonstige indifferente Präparate
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id115288
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Künstliche tränenflüssigkeit und sonstige indifferente präparate in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8517b05e-a358-41d8-beb0-b9b1f16065f6 GET /v1/drugs/8517b05e-a358-41d8-beb0-b9b1f16065f6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oogdruppels, oplossing",
"route": "Oculair gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h115288_smpc.pdf",
"strength": null,
"atc_label": "Artificial Tears And Other Indifferent Preparations",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg115288",
"excipients": [
"GLYCEROL (E 422)",
"NATRIUMHYDROXIDE (E 524)",
"WATER VOOR INJECTIE"
],
"substances": [
"CARBOMEER 981",
"NATRIUMHYALURONAAT"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h115288.pdf",
"authorised_at": "2015/05/28",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "115288",
"additional_monitoring": "N"
}See everything about künstliche tränenflüssigkeit und sonstige indifferente präparate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.